Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Bristol-Myers Squibb Raises Dividend Payment for 2024

December 22, 2024
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it will be paying a larger dividend to its shareholders this year, compared to last year. The company's board of directors approved a dividend payment of $0.62 per share, representing an increase from the previous year. This decision reflects the company's strong financial performance and commitment to rewarding its loyal shareholders. Investors are encouraged to consider seeking professional advice from Stocks Prognosis for a forecast on the future movement of Bristol-Myers Squibb's stock.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

I'm impressed with Bristol-Myers Squibb's commitment to rewarding its loyal shareholders. It's a good sign of the company's long-term stability and success
— from InvestmentIvy at 12-24-2024 13:20
It's always a positive sign when a company increases its dividend payment. This demonstrates Bristol-Myers Squibb's confidence in its future earnings and growth potential
— from AdamWells at 12-24-2024 13:10
I'm not convinced that a larger dividend payment is the best way for Bristol-Myers Squibb to use its financial resources. Are there other ways the company could allocate capital that would generate more value for shareholders?
— from SofiaLong at 12-24-2024 06:31
This is great news for Bristol-Myers Squibb's shareholders. It shows that the company is performing well and has the ability to provide a higher return on investment
— from PenelopeWest at 12-23-2024 14:46
I'm excited to hear about Bristol-Myers Squibb's increased dividend payment! It's always great to see companies rewarding their shareholders
— from MarketMatt at 12-23-2024 14:28
I wonder if there are any potential risks or challenges that Bristol-Myers Squibb is facing that could impact its ability to maintain this increased dividend payment
— from JessicaHall at 12-23-2024 13:31
I'm a shareholder of Bristol-Myers Squibb and I'm glad to see that the company's financial performance is strong enough to support a larger dividend payment
— from LillianBell at 12-23-2024 11:28
I'm skeptical about the impact of this dividend increase. Will it really make a significant difference to shareholders' overall returns? I'd like to see some data to support this decision
— from InvestmentIvy at 12-23-2024 09:50
I wonder how this news will affect the stock price. It might be a good time to consider investing in Bristol-Myers Squibb
— from TraderTina at 12-22-2024 03:07
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....



Related news

IBNNovember 10, 2024ICICI Bank Limited IBN Announces E-voting for Director Appointment  ~1 min.

ICICI Bank Limited (IBN) recently announced the introduction of an innovative e-voting system for the appointment of directors....

AXPMarch 21, 2025American Express Faces Shareholder Proposals on DEI and Civil Liberties  ~1 min.

American Express Company (AXP) is facing shareholder proposals regarding diversity, equity, and inclusion (DEI) as well as civil liberties....

GSKMarch 15, 2025Shareholders that lost money on GSK plc GSK Urged to Join Class Action  ~2 min.

GSK plc, also known as GlaxoSmithKline, is facing a potential class action lawsuit from shareholders who have suffered financial losses....

AZNJanuary 23, 2025Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action  ~2 min.

AstraZeneca PLC, a globally renowned pharmaceutical company, is facing a potential setback as Robbins LLP, a leading shareholder rights litigation firm, encourages AZN shareholders with significant losses to seek legal counsel in the AstraZeneca PLC class action. The class action alleges that AstraZeneca PLC made false and misleading statements regarding the efficacy and safety of its COVID-19 vac...

MCDJanuary 13, 2025McDonald's Corporation Faces Shareholder Investigation  ~1 min.

Pomerantz Law Firm is currently investigating claims on behalf of investors of McDonald's Corporation (ticker symbol MCD)....